ES8201981A1 - Un procedimiento para la preparacion de nuevos derivados de hidantoina - Google Patents

Un procedimiento para la preparacion de nuevos derivados de hidantoina

Info

Publication number
ES8201981A1
ES8201981A1 ES499433A ES499433A ES8201981A1 ES 8201981 A1 ES8201981 A1 ES 8201981A1 ES 499433 A ES499433 A ES 499433A ES 499433 A ES499433 A ES 499433A ES 8201981 A1 ES8201981 A1 ES 8201981A1
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
hereinbefore defined
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES499433A
Other languages
English (en)
Other versions
ES499433A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES499433A0 publication Critical patent/ES499433A0/es
Publication of ES8201981A1 publication Critical patent/ES8201981A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE IDANTIONA DE FORMULA (I), DONDE N ES UN NUMERO ENTERO DE 0 A 5; X ES CO, CS O CH2; Y ES -CH2-CH2-; R1 ES CH2-NR5R6, DONDE R5 Y R6 SON INDEPENDIENTEMENTE HIDROGENO O ALQUILO C1-6; R2 ES HIDROGENO O ALQUILO C1-4; R3 ES ALQUILO C1-9, O CILOALQUILO C5-8; R4 ES HIDROGENO O ALQUILO C1-6, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN SOMETER A REACCION DE CICLACION UN COMPUESTO DE FORMULA (II), DONDE R11 ES HIDROXI O HIDROXI PROTEGIDO; R12 ES UN GRUPO ALQUILO C1-6, Y X, Y, R1,R2,R3,R4 Y N TIENE LOS SIGNIFICADOS YA INDICADOS, Y POSTERIORMENTE, SI SE DESEA, CONVERTIR EL COMPUESTO ASI FORMADO, DONDE X ES CS, EN OTRO COMPUESTO, DONDE X ES CH2, Y SE DESEA, CONVERTIR UN GRUPO Y O R4, EN OTRO GRUO DIFERENTE Y O R4, O DESPROTEGER EL GRUPO R11 PROTEGIDO.
ES499433A 1979-05-23 1981-02-13 Un procedimiento para la preparacion de nuevos derivados de hidantoina Expired ES8201981A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7917931 1979-05-23

Publications (2)

Publication Number Publication Date
ES499433A0 ES499433A0 (es) 1982-01-01
ES8201981A1 true ES8201981A1 (es) 1982-01-01

Family

ID=10505375

Family Applications (3)

Application Number Title Priority Date Filing Date
ES491761A Granted ES491761A0 (es) 1979-05-23 1980-05-22 Un procedimiento para la preparacion de nuevos derivados de hidantoina.
ES499433A Expired ES8201981A1 (es) 1979-05-23 1981-02-13 Un procedimiento para la preparacion de nuevos derivados de hidantoina
ES499432A Granted ES499432A0 (es) 1979-05-23 1981-02-13 Un procedimiento para la preparacion de nuevos derivados de hidantoina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES491761A Granted ES491761A0 (es) 1979-05-23 1980-05-22 Un procedimiento para la preparacion de nuevos derivados de hidantoina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES499432A Granted ES499432A0 (es) 1979-05-23 1981-02-13 Un procedimiento para la preparacion de nuevos derivados de hidantoina

Country Status (8)

Country Link
US (1) US4315022A (es)
EP (1) EP0020039A1 (es)
JP (1) JPS55162776A (es)
AU (1) AU5862380A (es)
DK (1) DK220680A (es)
ES (3) ES491761A0 (es)
IL (1) IL60040A0 (es)
ZA (1) ZA802765B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496577A (en) * 1983-10-05 1985-01-29 Syntex (U.S.A.) Inc. Imidazolidinone prostaglandins, compositions and use
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.
US6300503B1 (en) * 1999-12-17 2001-10-09 Dixie Chemical Company Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same
DK1765785T3 (da) * 2004-07-02 2009-11-02 Allergan Inc Prostaglandinanaloger
CA2571786A1 (en) * 2004-07-02 2006-02-09 Allergan, Inc. Prostaglandin analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204068A (en) * 1976-06-03 1980-05-20 Burroughs Wellcome Co. Nitrogen heterocycles
US4152445A (en) * 1976-12-18 1979-05-01 Beecham Group Limited 1-(3-Hydroxyalk-1-yl)-5-(carboxyalkyl)hydantoin derivatives
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues

Also Published As

Publication number Publication date
ES499433A0 (es) 1982-01-01
ZA802765B (en) 1981-05-27
ES8201980A1 (es) 1982-01-01
US4315022A (en) 1982-02-09
ES499432A0 (es) 1982-01-01
AU5862380A (en) 1980-11-27
EP0020039A1 (en) 1980-12-10
IL60040A0 (en) 1980-07-31
DK220680A (da) 1980-11-24
JPS55162776A (en) 1980-12-18
ES8105302A1 (es) 1981-06-01
ES491761A0 (es) 1981-06-01

Similar Documents

Publication Publication Date Title
ES8206491A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
ES8107157A1 (es) Procedimiento para la preparacion de 2-cloro-6-nitroanilinas
ES8106142A1 (es) Un procedimiento para la preparacion de un indol
ES8401044A1 (es) Procedimiento para preparar derivados de piridona.
ES482134A1 (es) Un procedimiento para preparar derivados de 1-(3-mercapto- 2-metilpropanoil)-prolil-aminoacido.
DK149885D0 (da) Fremgangsmaade til fremstilling af optisk aktive alpha-arylalkansyrer og mellemprodukter til brug herved
IL75583A0 (en) Pyrazole analogs of mevalonolactone and derivatives thereof,their preparation and pharmaceutical compositions containing them
ES8301881A1 (es) Un procedimiento para la preparacion de derivados de ariletanolamina que tienen actividad antiobesidad yno hploglicemi- ca.
IL62110A (en) Pharmaceutical compositions containing(substituted)phenyl alkyl imidazole derivatives,some new such compounds and their preparation
ES8303395A1 (es) "procedimiento de preparar compuestos benzoxepinicos y analogos".
ES435458A1 (es) Un procedimiento para la preparacion de sales metalicas de beta-alaninas n, n-disustituidas.
ES483289A1 (es) Un procedimiento para la preparacion de 1,2,3,5, tetrahidro-himidazotienopirimidin-2-onas.
ES8201980A1 (es) Un procedimiento para la preparacion de nuevos derivados de hidantoina
ES8200669A1 (es) Un procedimiento para la preparacion de nuevos compuestos iminicos heterociclicos
ES8103056A1 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES454668A1 (es) Procedimiento para la preparacion de nuevas homoftalimidas.
ES483253A1 (es) Un procedimiento para la prepracion de derivados de pipera- zin-2,5-diona.
ES466363A1 (es) Procedimiento para la obtencion de acido n-9,10-dihidro - lisergil-m-amino-benzoico
ES464150A1 (es) Procedimiento para la preparacion de compuestos derivados defenil-amino-2-imidazolina
ES8308860A1 (es) "un procedimiento para la preparacion de pirimid-2-onas".
ES485492A1 (es) Un procedimiento para preparar derivados de triazol
ES8104242A1 (es) Un procedimiento para la preparacion de nuevos derivados de hidantoina.
ES8402838A1 (es) Procedimiento para la obtencion de quinazolinonas triciclicas.
ES484476A1 (es) Procedimiento para la preparacion de diuretanos
ES478361A1 (es) Un procedimiento para la produccion de compuestos que poseenactividad farmacologica como relajadores de los musculos.